Vulvar Cancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001-2018.
Abbey B BerensonMihyun ChangErnest T HawkLois Michelle RamondettaThao N HoangPublished in: Cancer prevention research (Philadelphia, Pa.) (2022)
We found evidence that HPV vaccinations likely contributed to a decrease in the incidences of vulvar carcinoma in situ and invasive vulvar carcinoma among 20- to 44-year-old women between 2001 and 2018. Our data add to the growing evidence that HPV vaccinations are reducing the incidence of HPV-related anogenital cancers.
Keyphrases
- cervical cancer screening
- high grade
- sentinel lymph node
- risk factors
- papillary thyroid
- polycystic ovary syndrome
- type diabetes
- lymph node
- early stage
- pregnancy outcomes
- big data
- squamous cell carcinoma
- squamous cell
- childhood cancer
- adipose tissue
- radiation therapy
- machine learning
- neoadjuvant chemotherapy
- rectal cancer
- data analysis